Clinical Trial Update: Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating efficacy and safety of Lanreotide Autogel for tumor stabilization in progressive neuroendocrine tumours.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumours

Drugs mentioned

• Lanreotide Autogel (lanreotide)

Snippet

Sponsor: Ipsen | Conditions: Neuroendocrine Tumours | Phase 2 | Status: COMPLETED